Abstract
AbstractHyperprolinemia type I (HPI) is an autosomal recessive metabolic disorder caused by defects in proline oxidase. We herein describe a case of a patient with HPI and harboring the NM_016335.4 (PRODH_v001):c.1397 C > T (p.T466M) mutation and polymorphisms in the PRODH gene, as detected by plasma amino acid analysis and Sanger sequencing. The patient presented with short stature, carbohydrate-rich dietary preferences, and mild intellectual disability that was suggestive of a neurodevelopmental or learning disorder.
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Biochemistry
Reference20 articles.
1. Afenjar, A. et al. Early neurological phenotype in 4 children with biallelic PRODH mutations. Brain Dev. 29, 547–552 (2007).
2. Di Rosa, G. et al. Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. Psychiatr. Genet. 18, 40–42 (2008).
3. Di Rosa, G., Nicotera, A. G., Lenzo, P., Spanò, M. & Tortorella, G. Long-term neuropsychiatric follow-up in hyperprolinemia type I. Psychiatr. Genet. 24, 172–175 (2014).
4. Oyanagi, K. et al. Clinical, biochemical and enzymatic studies in type I hyperprolinemia associated with chromosomal abnormality. Tohoku J. Exp. Med. 151, 465–475 (1987).
5. Ishikawa, Y. et al. A case of type I hyperprolinemia associated with photogenic epilepsy (in Japanese). No Hattatsu (Tokyo) 23, 81–86 (1991).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献